Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma

PURPOSE: Metastatic melanoma patients have a poor prognosis. No chemotherapy regimen has improved overall survival. More effective treatments are needed. Docetaxel has clinical activity in melanoma and may be more active when combined with vinorelbine. Granulocyte–macrophage colony-stimulating facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Eroglu, Zeynep, Kong, Kevin M., Jakowatz, James G., Samlowski, Wolfram, Fruehauf, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180631/
https://www.ncbi.nlm.nih.gov/pubmed/21769667
http://dx.doi.org/10.1007/s00280-011-1703-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180631/
https://www.ncbi.nlm.nih.gov/pubmed/21769667
http://dx.doi.org/10.1007/s00280-011-1703-z

Ejemplares similares